Jumping from 0.25mg to 1.0mg because the first two weeks felt fine can result in a rough surprise in week 5
With several domestic pharmaceutical companies preparing to launch branded generic formulations, millions of patients may soon gain access to effective weight-loss therapy
They will determine the appropriate dosage and frequency that best suits your individual needs
The SELECT trial result - 20% reduction in major cardiovascular events with weekly semaglutide 2.4mg in adults with established cardiovascular disease plus overweight/obesity - was the first time a weight-loss medication demonstrated cardiovascular outcome benefits in a major randomized controlled trial
Potential Cancer Risk Reduction A large population study of over 1.6 million adults found that GLP-1 use was linked to lower risk of several obesity-associated cancers, including colon, liver, pancreas, kidney, gallbladder, endometrial, and esophageal
M., Auker, C